Navigation Links
Halozyme To Present New Data On PEGPH20 In Pancreatic Cancer At American Society of Clinical Oncology Annual Meeting
Date:5/15/2013

ic pancreatic adenocarcinoma, survival rates are the lowest of any cancer. In 2013, it is estimated that almost 45,000 new cases of pancreatic cancer will be diagnosed. About one-in-78 people in the U.S. will develop the disease, affecting equal numbers of men and women, almost always after the age of 45. Its tendency to spread prior to diagnosis makes it the fourth deadliest cancer with a less than six percent five-year relative survival rate, with more than 38,000 people succumbing to the disease each year.1-2

About Halozyme
Halozyme Therapeutics is a biopharmaceutical company dedicated to developing and commercializing innovative products that advance patient care. With a diversified portfolio of enzymes that target the extracellular matrix, the Company's research focuses primarily on a family of human enzymes, known as hyaluronidases, which increase the absorption and dispersion of biologics, drugs and fluids. Halozyme's pipeline addresses therapeutic areas, including diabetes, oncology and dermatology that have significant unmet medical need. The Company markets Hylenex® recombinant (hyaluronidase human injection) and has partnerships with Roche, Pfizer, Baxter, ViroPharma and Intrexon. Halozyme is headquartered in San Diego, CA. For more information on how we are innovating, please visit our corporate website at www.halozyme.com.

Safe Harbor Statement
In addition to historical information, the statements set forth above include forward-looking statements including, without limitation, statements concerning the possible benefits and attributes of PEGPH20, the anticipated enrollment of patients and possible outcomes for the referenced Phase 2 clinical trial, the possible method of action of PEGPH20 and the anticipated presentation of data from Halozyme's Phase 1b trial and the development of the HA diagnostic tool and the potenti
'/>"/>

SOURCE Halozyme Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Halozyme Therapeutics to Present at the 30th Annual J.P. Morgan Healthcare Conference
2. Halozyme to Host Fourth Quarter and 2011 Year-End Financial Results Conference Call
3. Halozyme Therapeutics to Present at Two Upcoming Investor Conferences in March
4. Halozyme to Host Second Quarter Financial Results Conference Call
5. Halozyme to Host Fourth Quarter and 2012 Year-End Financial Results Conference Call
6. Keryx Biopharmaceuticals, Inc. Announces Upcoming Poster Presentations of Zerenex™ (Ferric Citrate) at the Upcoming American Society of Nephrology Kidney Week 2011 Annual Meeting
7. ChemoCentryx Presents Positive Results for Novel CCR2 Inhibitor in Preclinical Models of Diabetic Nephropathy at the 44th Annual Meeting of the American Society of Nephrology
8. Organovo to Present at Lazard Capital Markets 8th Annual Healthcare Conference
9. Chimerix Announces Late-Breaking Poster Presentation at Kidney Week 2011 Annual Meeting
10. Pharmasset to Present at the Lazard Capital Markets Healthcare Conference
11. Masimo to Present at 23rd Annual Piper Jaffray Health Care Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2015)... May 20, 2015 The global genotyping ... 22.3% during the forecast period of 2015 to 2020 ... being used in drug discovery and development process and ... growth. In addition to this,heavy investments by key manufacturers ... are also propelling market growth. Browse 113 market data ...
(Date:5/20/2015)... May 20, 2015  Marc Tessier-Lavigne, president of ... of $100 million from The Marie-Josée and Henry ... laboratory building that will be the centerpiece of ... and Henry R. Kravis Research Building, two stories ... spanning approximately three city blocks following the shoreline ...
(Date:5/20/2015)...  Resolution Bioscience announced today the successful results from ... , a blood-based liquid biopsy for an ALK-gene fusion driver ... most common form of this cancer. Researchers or clinicians ... personalized therapies and direct them into clinical trials with ... Health, the CLIA authority in Washington State ...
(Date:5/20/2015)... France, Cambridge, MA (PRWEB) May 20, 2015 ... high quality transporter assay services for Drug-Drug Interactions ... and Rhenovia Pharma, a world leader in assessing ... Translational Quantitative Systems Pharmacology supported by biosimulation, announced ... , The agreement allows both companies to expand ...
Breaking Biology Technology:Genotyping Market Growing at 22.3% CAGR to 2020: Research Based on Technology, Applications, Opportunities, Challenges and Key Players. 2Genotyping Market Growing at 22.3% CAGR to 2020: Research Based on Technology, Applications, Opportunities, Challenges and Key Players. 3Genotyping Market Growing at 22.3% CAGR to 2020: Research Based on Technology, Applications, Opportunities, Challenges and Key Players. 4Genotyping Market Growing at 22.3% CAGR to 2020: Research Based on Technology, Applications, Opportunities, Challenges and Key Players. 5The Marie-Josee and Henry R. Kravis Foundation Provides Landmark Gift of $100 Million to The Rockefeller University 2The Marie-Josee and Henry R. Kravis Foundation Provides Landmark Gift of $100 Million to The Rockefeller University 3The Marie-Josee and Henry R. Kravis Foundation Provides Landmark Gift of $100 Million to The Rockefeller University 4Resolution Bioscience Receives CLIA Certification for its Diagnostic Laboratory and Launches CLIA-Certified Liquid Biopsy for Lung Cancer 2Optivia Biotechnology Inc. and Rhenovia Pharma Sign Partnership Agreement 2Optivia Biotechnology Inc. and Rhenovia Pharma Sign Partnership Agreement 3
... , Mammalian , ... Human, B lymphomas: BJAB,P3HR-1, B95-8, UC729-6 , ... carcinoma , Human epithelial cells , ... Human fibroblast , ...
... Ralph Panstruga, Brigitte Schauf, and Paul Schulze-Lefert, ... , Abstract ... bombardment is widely used as a means , ... study , we describe the use ...
... Volker Wippersteg, Katja Kapp, Werner Kunz, and Christoph G Grevelding,Institute for Genetics, ... , ... Schistosomes are parasitic helminths that cause bilharzia (schistosomiasis) , ... (Savioli et al.1997). , One ...
Cached Biology Technology:Examples of Electro-Transfected Eukaryotic and Prokaryotic Cells 2Examples of Electro-Transfected Eukaryotic and Prokaryotic Cells 3Examples of Electro-Transfected Eukaryotic and Prokaryotic Cells 4Examples of Electro-Transfected Eukaryotic and Prokaryotic Cells 5Single-Cell Complementation of Barley Mlo Mutants Using a PDS-1000/He Hepta System 2Single-Cell Complementation of Barley Mlo Mutants Using a PDS-1000/He Hepta System 3Single-Cell Complementation of Barley Mlo Mutants Using a PDS-1000/He Hepta System 4Single-Cell Complementation of Barley Mlo Mutants Using a PDS-1000/He Hepta System 5Single-Cell Complementation of Barley Mlo Mutants Using a PDS-1000/He Hepta System 6Biolistic Gene Transfer to Generate Transgenic Schistosomes, Rev A 2Biolistic Gene Transfer to Generate Transgenic Schistosomes, Rev A 3Biolistic Gene Transfer to Generate Transgenic Schistosomes, Rev A 4Biolistic Gene Transfer to Generate Transgenic Schistosomes, Rev A 5Biolistic Gene Transfer to Generate Transgenic Schistosomes, Rev A 6Biolistic Gene Transfer to Generate Transgenic Schistosomes, Rev A 7Biolistic Gene Transfer to Generate Transgenic Schistosomes, Rev A 8Biolistic Gene Transfer to Generate Transgenic Schistosomes, Rev A 9
(Date:4/27/2015)...  For more than four decades, AUVSI,s Unmanned ... premier worldwide event for the unmanned land, sea, and ... for any local, national, or trade news organization interested ... and current applications of unmanned technologies. The conference will ... billion industry, and how it will soon impact the ...
(Date:4/20/2015)... , April 20, 2015 The ... Glenbeigh Records Management (GRM), Ireland,s ... Dubai Islamic Bank. Having built up an impressive track record ... a leading player within the records management sector in ... to double is GCC staffbase and employ a further eight ...
(Date:4/13/2015)... CHICAGO , April 13, 2015  higi, a ... with ways to more fully engage with their communities ... its industry-leading, privacy protected and secure API.  ... API enables the most accessible, affordable, and convenient vehicle ... The API will ...
Breaking Biology News(10 mins):UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 2UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 3UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 4UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 5Glenbeigh Records Management Wins Contract With Dubai Islamic Bank 2Glenbeigh Records Management Wins Contract With Dubai Islamic Bank 3higi Launches Seamless Access to HIPAA-Compliant Health Outcomes and Activity Data 2higi Launches Seamless Access to HIPAA-Compliant Health Outcomes and Activity Data 3
... of the greatest mysteries of modern coral reefs is how ... has long existed in the record of coral evolution. ... in sea level and changes in the Earth,s climate between ... many "old" corals went extinct, and the modern reef corals ...
... the University of Alberta have made a discovery that may ... cow disease, adapt in order to spread between various types ... discovered that a miniscule change in the prions, makeup appears ... mimic and recreate new strains with which it comes into ...
... For hundreds of years, naturalists and scientists have ... differences. But now, new genetic techniques are revealing ... visible differences. In a just-published study, evolutionary ... the American Museum of Natural History (AMNH) combine ...
Cached Biology News:University of Miami geologists to address the mystery of an evolution gap in reef corals 2Discovery may explain how prion diseases spread between different types of animals 2Researchers develop tools for discovering new species 2Researchers develop tools for discovering new species 3
... GeneMaths XT is undoubtedly the most complete ... advanced concept of layers and subsets makes ... layers for different data outputs, for example ... etc., as well as different subsets of ...
...
...
... for Mac OS X provides the most ... protein sequence analysis and molecular biology data ... 1). With Vector NTI Suite you can ... publicize diverse types of molecular biology data ...
Biology Products: